WALTHAM, Mass.–(BUSINESS WIRE)–May 12, 2021– PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash.

Read the full press release »